Ms. Li Yu is primarily responsible for the management of operations and administration. After joining HighTide in 2011, she played a key role in closing multiple rounds of financing, obtaining U.S. FDA “Fast Track Designation” for two core programs, and successfully completing multiple Phase 2 clinical trials globally for the Company.
Ms. Yu has more than 20 years of experience in the pharmaceutical and biotech industry. Prior to HighTide, she served as an engineer supervising production in Shandong Xinhua Pharmaceutical Co., Ltd., senior manager of registration department in Shanghai Youseen New Drug R&D Co., Ltd., manager of regulatory affairs in Stealth Peptides International (Shanghai) Inc., and drug registration manager of All Pharma (Shanghai) Trading Co., Ltd., respectively.
Ms. Yu holds a bachelor's degree in Traditional Chinese Medicine from Shandong University of Traditional Chinese Medicine and a master's degree in Traditional Chinese Medicine from Shanghai University of Traditional Chinese Medicine.
© 2023 HighTide Therapeutics Inc.